Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
about
Neuroendocrine Carcinomas of the Gastroenteropancreatic System: A Comprehensive ReviewManagement of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphologyGastroenteropancreatic Well-Differentiated Grade 3 Neuroendocrine Tumors: Review and Position Statement.The high-grade (WHO G3) pancreatic neuroendocrine tumor category is morphologically and biologically heterogenous and includes both well differentiated and poorly differentiated neoplasms.Does the WHO 2010 classification of pancreatic neuroendocrine neoplasms accurately characterize pancreatic neuroendocrine carcinomas?(68)Ga-DOTATOC PET and gene expression profile in patients with neuroendocrine carcinomas: strong correlation between PET tracer uptake and gene expression of somatostatin receptor subtype 2Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas.Clinicopathological, treatment, and prognosis study of 43 gastric neuroendocrine carcinomas.Pancreatic Neuroendocrine Neoplasms: Basic Biology, Current Treatment Strategies and Prospects for the Future.High-grade poorly differentiated neuroendocrine carcinomas of the gastroenteropancreatic system: from morphology to proliferation and back.Unraveling tumor grading and genomic landscape in lung neuroendocrine tumors.Neuroendocrine tumor G3: a pancreatic well-differentiated neuroendocrine tumor with a high proliferative rate.Mixed Neuroendocrine-Nonneuroendocrine Neoplasms (MiNENs): Unifying the Concept of a Heterogeneous Group of Neoplasms.Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology: Well Differentiated Versus Poorly Differentiated.Prognostic markers in smear preparations for pancreatic endocrine neoplasms: A cytomorphologic study and statistical analysis of 20 potential prognostic features.Metastatic neoplasms to the pancreas diagnosed by fine-needle aspiration/biopsy cytology: A 15-year retrospective analysis.Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma.Surgical Treatment as a Principle for Patients with High-Grade Pancreatic Neuroendocrine Carcinoma: A Nordic Multicenter Comparative Study.Ki-67 labeling index of neuroendocrine tumors of the lung has a high level of correspondence between biopsy samples and surgical specimens when strict counting guidelines are applied.Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases.Assessment of cytologic differentiation in high-grade pancreatic neuroendocrine neoplasms: A multi-institutional study.Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease.Cyto-histology in NET: what is necessary today and what is the future?Gastroenteropancreatic neuroendocrine neoplasms: selected pathology review and molecular updates.Well-differentiated pancreatic neuroendocrine tumours (PanNETs) and poorly differentiated pancreatic neuroendocrine carcinomas (PanNECs): concepts, issues and a practical diagnostic approach to high-grade (G3) cases.Thymus neuroendocrine tumors with CTNNB1 gene mutations, disarrayed ß-catenin expression, and dual intra-tumor Ki-67 labeling index compartmentalization challenge the concept of secondary high-grade neuroendocrine tumor: a paradigm shift.Downgrading of a G3 Neuroendocrine Tumor to a G2 Tumor: Can First-Line Cytotoxic Chemotherapy Change the Tumor Biology?Clinical relevance of different WHO grade 3 pancreatic neuroendocrine neoplasms based on morphology.[What is new in the pathology of pancreatic neuroendocrine tumors?].Establishment of preclinical chemotherapy models for gastroenteropancreatic neuroendocrine carcinoma.Small cell carcinoma of the stomach: A report of two cases and a review of the literature.Pancreatic neuroendocrine tumors
P2860
Q26768483-853F6BA9-152C-4B68-9F88-0F43F753049AQ28078501-CC32536C-61D4-4842-AD85-CD3FA47F9AA1Q30249051-F5A0F3DA-33C0-434C-81C7-13AFD348CECAQ34464857-5F7B7C3A-E4E8-4DAE-ABC2-4F654C9B0E56Q36300517-054447BE-4A35-4C5E-9A91-DE2D74E3DC1DQ36568335-976E0FF9-7ADB-4A21-B651-27E2DD4829A7Q37182620-4A65AF39-202E-4917-8497-8BC38532B3C0Q37624511-428FD2E9-EEB7-47DA-920C-AE668BECCC0CQ37631597-A71987C9-FDBB-4A09-95A9-AAA46344DF92Q38203186-ED16822E-8BDA-44CA-8C3A-F23466BA266BQ38207553-407F7509-C24E-410C-9038-B0C3894ABAB1Q38600057-37426A28-9963-436D-B6A0-5BCA3734C5F7Q38832413-051236EC-4594-4501-B13F-22230C97D589Q39271421-2BF310F1-FF5E-4E1B-B806-73159D12680AQ39301100-E8306935-51C8-4669-89EE-3B407E08067DQ39366026-8389CFC6-0314-43AF-B366-107424BDC825Q39709503-5C708050-0B61-441C-84E7-1B3A650260B8Q40200855-8B2846C5-7D3F-4787-BF7C-17F8BAB89D2BQ40395607-27392A08-3459-4E35-8EE9-57AA391814FFQ47358369-E2CEA009-B5C5-4FE2-A686-2DA7824EEDBCQ47594456-2CE4DE4C-36D7-45B1-894D-04ABEADE676BQ47871784-3AB98B24-EC85-4732-9CD3-176D039EC534Q47965331-2E9CA921-AFDD-4759-9B5A-2D8C25602E06Q48120130-32DF2915-F833-4712-BD55-63C2E6EC9B92Q48120139-F975DAA6-347F-4827-84F4-362A455985E9Q48221145-E4DCFF3B-44BD-4C57-B0D3-6C093734B98EQ49732322-768E77E4-60FE-4D7F-A3C3-36A53CC8B3D0Q50355400-EA9F9E8A-2B54-4E35-BF95-47BF0A40EEF4Q53219871-A139226E-2DE3-478D-9A36-D9A1CE4A24F2Q55044222-3B8F6AD7-6A9C-416B-84A0-729CFF79F95AQ55363415-DC33FD76-0A67-4704-BA38-B71E3651A14AQ56917284-0AA4F90C-2034-4381-917C-71EFAD116368
P2860
Poorly differentiated neuroendocrine carcinomas of the pancreas: a clinicopathologic analysis of 44 cases.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Poorly differentiated neuroend ...... thologic analysis of 44 cases.
@en
Poorly differentiated neuroend ...... thologic analysis of 44 cases.
@nl
type
label
Poorly differentiated neuroend ...... thologic analysis of 44 cases.
@en
Poorly differentiated neuroend ...... thologic analysis of 44 cases.
@nl
prefLabel
Poorly differentiated neuroend ...... thologic analysis of 44 cases.
@en
Poorly differentiated neuroend ...... thologic analysis of 44 cases.
@nl
P2093
P2860
P50
P1476
Poorly differentiated neuroend ...... athologic analysis of 44 cases
@en
P2093
Alyssa M Krasinskas
Burcu Saka
Chanjuan Shi
Christopher L Wolfgang
David S Klimstra
Diane L Reidy
Efsevia Vakiani
Jey-Hsin Chen
Kee-Taek Jang
Laura Tang
P2860
P304
P356
10.1097/PAS.0000000000000169
P407
P577
2014-04-01T00:00:00Z